Skip to main content

Notice for elasomeran and davesomeran (Moderna Australia Pty Ltd)

Active ingredients
elasomeran and davesomeran
Date of review outcome
Lapse date
Type
Provisional determination
Indication
Booster for active immunisation to prevent COVID-19 caused by SARS-CoV-2
Therapeutic area
Infectious diseases

Help us improve the Therapeutic Goods Administration site